Combination and high-dose atypical antipsychotic therapy in patients with schizophrenia: systematic review.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed, 5 syntheses or guidelines pooled it.

1. Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis.The international journal of neuropsychopharmacology · 2021
   Pooled it
2. Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia.PloS one · 2020
   Pooled it
3. Optimization of Antipsychotic and Benzodiazepine Drugs in Patients with Severe Mental Disorders in an Intensive Case Management Program.Community mental health journal · 2019
   Pooled it
4. Antipsychotic combinations for schizophrenia.The Cochrane database of systematic reviews · 2017
   Pooled it
5. Wendan decoction (温胆汤) for treatment of schizophrenia: a systematic review of randomized controlled trials.Chinese journal of integrative medicine · 2016
   Pooled it
6. Xanomeline-Trospium: A Novel Therapeutic for the Treatment of Schizophrenia.The Annals of pharmacotherapy · 2025
   Review
7. Check the effects: systematic assessment of antipsychotic side-effects in an inpatient cohort.Therapeutic advances in psychopharmacology · 2020
   Article
8. Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews.BMC psychiatry · 2018
   Review
9. Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.International journal of molecular sciences · 2017
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.